Glucocorticoids: Mechanisms of Action and Anti-inflammatory Potential in Asthma

Overview

Journal Mediators Inflamm

Publisher Wiley

Specialties Biochemistry
Pathology

Date 1998 Oct 29

PMID 9792333

Citations 63

Authors

V H van der Velden

Affiliations

Soon will be listed here.

Abstract

GLUCOCORTICOIDS are potent inhibitors of inflammatory processes and are widely used in the treatment of asthma. The anti-inflammatory effects are mediated either by direct binding of the glucocorticoid/glucocorticoid receptor complex to glucocorticoid responsive elements in the promoter region of genes, or by an interaction of this complex with other transcription factors, in particular activating protein-1 or nuclear factor-kappaB. Glucocorticoids inhibit many inflammation-associated molecules such as cytokines, chemokines, arachidonic acid metabolites, and adhesion molecules. In contrast, anti-inflammatory mediators often are up-regulated by glucocorticoids. In vivo studies have shown that treatment of asthmatic patients with inhaled glucocorticoids inhibits the bronchial inflammation and simultaneously improves their lung function. In this review, our current knowledge of the mechanism of action of glucocorticoids and their anti-inflammatory potential in asthma is described. Since bronchial epithelial cells may be important targets for glucocorticoid therapy in asthma, the effects of glucocorticoids on epithelial expressed inflammatory genes will be emphasized.

Citing Articles

Ginsenoside Rc prevents dexamethasone-induced muscle atrophy and enhances muscle strength and motor function.

Kim A, Park S, Kim N, Park M, Cha S J Ginseng Res. 2025; 49(1):42-52.

PMID: 39872283 PMC: 11764205. DOI: 10.1016/j.jgr.2024.09.002.

Evolving Treatment Strategies for Systemic Lupus Erythematosus in Clinical Practice: A Narrative Review.

Kaye A, Tassin J, Upshaw W, Patel C, Hawkins A, Burroughs C Cureus. 2025; 16(12):e75062.

PMID: 39759646 PMC: 11698531. DOI: 10.7759/cureus.75062.

Effects of immunosuppression after limb fracture in mice on nociceptive, cognitive, and anxiety-related outcomes.

Sahbaie P, Guo T, Shi X, Kingery W, Clark J Pain Rep. 2024; 9(5):e1179.

PMID: 39263006 PMC: 11390048. DOI: 10.1097/PR9.0000000000001179.

Nanoemulsion Improves the Anti-Inflammatory Effect of Intraperitoneal and Oral Administration of Carvacryl Acetate.

Souza R, Opretzka L, Morais M, Melo C, Oliveira B, de Sousa D Pharmaceuticals (Basel). 2024; 17(1).

PMID: 38276002 PMC: 10821396. DOI: 10.3390/ph17010017.

A Double Hit to Ubiquitination Leading to a New Diagnosis of VEXAS Syndrome.

Pozdniakova H, Vedire A, Kadakia A, Imburgio S, Bajwa R, Gupta V J Med Cases. 2023; 14(9-10):327-331.

PMID: 37868330 PMC: 10586336. DOI: 10.14740/jmc4127.

References

Bentley A, Hamid Q, Robinson D, Schotman E, Meng Q, Assoufi B . Prednisolone treatment in asthma. Reduction in the numbers of eosinophils, T cells, tryptase-only positive mast cells, and modulation of IL-4, IL-5, and interferon-gamma cytokine gene expression within the bronchial mucosa. Am J Respir Crit Care Med. 1996; 153(2):551-6. DOI: 10.1164/ajrccm.153.2.8564096. View

Robinson D, Assoufi B, Durham S, Kay A . Eosinophil cationic protein (ECP) and eosinophil protein X (EPX) concentrations in serum and bronchial lavage fluid in asthma. Effect of prednisolone treatment. Clin Exp Allergy. 1995; 25(11):1118-27. DOI: 10.1111/j.1365-2222.1995.tb03259.x. View

Levine S, Logun C, Chopra D, Rhim J, Shelhamer J . Protein kinase C, interleukin-1 beta, and corticosteroids regulate shedding of the type I, 55 kDa TNF receptor from human airway epithelial cells. Am J Respir Cell Mol Biol. 1996; 14(3):254-61. DOI: 10.1165/ajrcmb.14.3.8845176. View

Krouwels F, Van der Heijden J, Lutter R, Van Neerven R, Jansen H, Out T . Glucocorticosteroids affect functions of airway- and blood-derived human T-cell clones, favoring the Th1 profile through two mechanisms. Am J Respir Cell Mol Biol. 1996; 14(4):388-97. DOI: 10.1165/ajrcmb.14.4.8600944. View

Takizawa H, Ohtoshi T, Yamashita N, Oka T, Ito K . Interleukin 6-receptor expression on human bronchial epithelial cells: regulation by IL-1 and IL-6. Am J Physiol. 1996; 270(3 Pt 1):L346-52. DOI: 10.1152/ajplung.1996.270.3.L346. View

Berkman N, Robichaud A, Krishnan V, Roesems G, Robbins R, Jose P . Expression of RANTES in human airway epithelial cells: effect of corticosteroids and interleukin-4, -10 and -13. Immunology. 1996; 87(4):599-603. PMC: 1384139. DOI: 10.1046/j.1365-2567.1996.477579.x. View

Levine S, Benfield T, Shelhamer J . Corticosteroids induce intracellular interleukin-1 receptor antagonist type I expression by a human airway epithelial cell line. Am J Respir Cell Mol Biol. 1996; 15(2):245-51. DOI: 10.1165/ajrcmb.15.2.8703481. View

DiDonato J, Saatcioglu F, Karin M . Molecular mechanisms of immunosuppression and anti-inflammatory activities by glucocorticoids. Am J Respir Crit Care Med. 1996; 154(2 Pt 2):S11-5. DOI: 10.1164/ajrccm/154.2_Pt_2.S11. View

Moller G, Overbeek S, van Helden-Meeuwsen C, Van Haarst J, Prens E, Mulder P . Increased numbers of dendritic cells in the bronchial mucosa of atopic asthmatic patients: downregulation by inhaled corticosteroids. Clin Exp Allergy. 1996; 26(5):517-24. View

10.

Dawes K, Cambrey A, Campa J, Bishop J, McAnulty R, Peacock A . Changes in collagen metabolism in response to endothelin-1: evidence for fibroblast heterogeneity. Int J Biochem Cell Biol. 1996; 28(2):229-38. DOI: 10.1016/1357-2725(95)00124-7. View

11.

Rizvi M, Katwa L, Spadone D, Myers P . The effects of endothelin-1 on collagen type I and type III synthesis in cultured porcine coronary artery vascular smooth muscle cells. J Mol Cell Cardiol. 1996; 28(2):243-52. DOI: 10.1006/jmcc.1996.0023. View

12.

Adcock I, Gilbey T, Gelder C, Chung K, Barnes P . Glucocorticoid receptor localization in normal and asthmatic lung. Am J Respir Crit Care Med. 1996; 154(3 Pt 1):771-82. DOI: 10.1164/ajrccm.154.3.8810618. View

13.

Adcock I, Stevens D, Barnes P . Interactions of glucocorticoids and beta 2-agonists. Eur Respir J. 1996; 9(1):160-8. DOI: 10.1183/09031936.96.09010160. View

14.

Barnes P . Nitric oxide and asthma. Res Immunol. 1995; 146(9):698-702. DOI: 10.1016/0923-2494(96)84921-2. View

15.

van Hal P, Overbeek S, Hoogsteden H, Zijlstra F, Murphy K, Oosterhoff Y . Eicosanoids and lipocortin-1 in BAL fluid in asthma: effects of smoking and inhaled glucocorticoids. J Appl Physiol (1985). 1996; 81(2):548-55. DOI: 10.1152/jappl.1996.81.2.548. View

16.

Verheggen M, van Hal P, Adriaansen-Soeting P, Goense B, Hoogsteden H, Brinkmann A . Modulation of glucocorticoid receptor expression in human bronchial epithelial cell lines by IL-1 beta, TNF-alpha and LPS. Eur Respir J. 1996; 9(10):2036-43. DOI: 10.1183/09031936.96.09102036. View

17.

Nakamura Y, Azuma M, Okano Y, Sano T, Takahashi T, Ohmoto Y . Upregulatory effects of interleukin-4 and interleukin-13 but not interleukin-10 on granulocyte/macrophage colony-stimulating factor production by human bronchial epithelial cells. Am J Respir Cell Mol Biol. 1996; 15(5):680-7. DOI: 10.1165/ajrcmb.15.5.8918375. View

18.

Berkman N, Robichaud A, Robbins R, Roesems G, Haddad E, Barnes P . Inhibition of inducible nitric oxide synthase expression by interleukin-4 and interleukin-13 in human lung epithelial cells. Immunology. 1996; 89(3):363-7. PMC: 1456556. DOI: 10.1046/j.1365-2567.1996.d01-745.x. View

19.

Keatings V, Jatakanon A, Worsdell Y, Barnes P . Effects of inhaled and oral glucocorticoids on inflammatory indices in asthma and COPD. Am J Respir Crit Care Med. 1997; 155(2):542-8. DOI: 10.1164/ajrccm.155.2.9032192. View

20.

Djukanovic R, Homeyard S, Gratziou C, Madden J, Walls A, Montefort S . The effect of treatment with oral corticosteroids on asthma symptoms and airway inflammation. Am J Respir Crit Care Med. 1997; 155(3):826-32. DOI: 10.1164/ajrccm.155.3.9117012. View